DexCom, Inc. (DXCM)
66.37
-0.69
(-1.03%)
USD |
NASDAQ |
Dec 31, 16:00
66.49
+0.12
(+0.18%)
Pre-Market: 20:00
DexCom Free Cash Flow: 1.062B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 6.917B |
| BioLife Solutions, Inc. | 10.56M |
| Krystal Biotech, Inc. | 165.59M |
| Boston Scientific Corp. | 3.824B |
| Tandem Diabetes Care, Inc. | -25.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 659.90M |
| Cash from Investing (Quarterly) | 192.80M |
| Cash from Financing (Quarterly) | -175.00M |
| Free Cash Flow Per Share (Quarterly) | 1.422 |
| Free Cash Flow to Equity (Quarterly) | 583.10M |
| Free Cash Flow to Firm (Quarterly) | 583.19M |
| Free Cash Flow Yield | 3.93% |